171:@0.890183:0.033217:0.921227:0.033217:0.921227:0.013052:0.890183:0.013052:0.010348:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
tophaceous gout.  patients can be reassured that it is :@0.076190:0.084931:0.485133:0.084931:0.485133:0.069149:0.076190:0.069149:0.005125:0.009903:0.010311:0.009223:0.010326:0.009782:0.009827:0.009903:0.009192:0.005866:0.005352:0.010175:0.009903:0.009192:0.005125:0.004188:0.009709:0.005367:0.008950:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005352:0.009782:0.010326:0.009223:0.005352:0.010311:0.009827:0.005367:0.004551:0.009827:0.010326:0.005866:0.005866:0.009192:0.004551:0.009827:0.010357:0.005352:0.005125:0.009223:0.010326:0.005125:0.005352:0.003024:0.005125:0.005367:0.003024:0.005866:0.004188
14:@0.209575:0.079633:0.219291:0.079633:0.219291:0.070479:0.209575:0.070479:0.004858:0.004858
possible for attacks to stop and for tophi to resolve with :@0.076193:0.099040:0.485133:0.099040:0.485133:0.083257:0.076193:0.083257:0.010311:0.009903:0.005866:0.005866:0.003024:0.010311:0.003024:0.009827:0.004415:0.004747:0.009903:0.004551:0.004400:0.010326:0.005125:0.005125:0.010326:0.009782:0.007590:0.005866:0.004400:0.005125:0.009903:0.004400:0.005866:0.005125:0.009903:0.010311:0.004400:0.010326:0.009223:0.010357:0.004400:0.004747:0.009903:0.004551:0.004400:0.005125:0.009903:0.010311:0.009223:0.003024:0.004400:0.005125:0.009903:0.004400:0.004551:0.009827:0.005866:0.009903:0.003024:0.008376:0.009827:0.004400:0.012564:0.003024:0.005125:0.009223:0.004188
effective treatment.:@0.076193:0.113148:0.223165:0.113148:0.223165:0.097366:0.076193:0.097366:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.004188:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188
WHen tO refer:@0.076190:0.146012:0.211825:0.146012:0.211825:0.125847:0.076190:0.125847:0.016631:0.012566:0.009609:0.013674:0.005174:0.007761:0.015522:0.005174:0.010718:0.009609:0.008870:0.009609:0.010718
General practitioners and internal medicine specialists :@0.076190:0.161901:0.485130:0.161901:0.485130:0.146118:0.076190:0.146118:0.013184:0.009827:0.009223:0.009827:0.004551:0.010326:0.003024:0.005730:0.010311:0.004551:0.010326:0.009782:0.005125:0.003024:0.005125:0.003024:0.009903:0.009223:0.009827:0.004551:0.005866:0.005715:0.010326:0.009223:0.010357:0.005730:0.003024:0.009223:0.005125:0.009827:0.004551:0.009223:0.010326:0.003024:0.005730:0.014182:0.009827:0.010357:0.003024:0.009782:0.003024:0.009223:0.009827:0.005730:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.005866:0.005125:0.005866:0.004188
often  manage  gout.  Referral  to  a  rheumatologist  be-:@0.076190:0.176009:0.480957:0.176009:0.480957:0.160227:0.076190:0.160227:0.009903:0.004747:0.005125:0.009827:0.009223:0.004188:0.002570:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.004188:0.002570:0.010175:0.009903:0.009192:0.005125:0.004188:0.004188:0.002570:0.009177:0.009827:0.004747:0.009827:0.004551:0.004551:0.010326:0.003024:0.004188:0.002570:0.005125:0.009903:0.004188:0.002570:0.010326:0.004188:0.002570:0.004551:0.009223:0.009827:0.009192:0.014182:0.010326:0.005125:0.009903:0.003024:0.009903:0.010175:0.003024:0.005866:0.005125:0.004188:0.002570:0.010311:0.009827:0.005020
comes necessary in the following situations::@0.076190:0.190118:0.392934:0.190118:0.392934:0.174335:0.076190:0.174335:0.009782:0.009903:0.014182:0.009827:0.005866:0.004188:0.009223:0.009827:0.009782:0.009827:0.005866:0.005866:0.010326:0.004551:0.008104:0.004188:0.003024:0.009223:0.004188:0.005125:0.009223:0.009827:0.004188:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.003024:0.009223:0.010175:0.004188:0.005866:0.003024:0.005125:0.009192:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188
•  Failure to reach disease control with first-line therapy.:@0.076190:0.204227:0.480942:0.204227:0.480942:0.188444:0.076190:0.188444:0.009162:0.004188:0.006804:0.007333:0.010326:0.003024:0.003024:0.009192:0.004551:0.009827:0.003916:0.005125:0.009903:0.003901:0.004551:0.009827:0.010326:0.009782:0.009223:0.003901:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.003916:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.003901:0.012564:0.003024:0.005125:0.009223:0.003916:0.003681:0.003681:0.004551:0.005866:0.005125:0.005020:0.003024:0.003024:0.009223:0.009827:0.003916:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188
•  Severe side effects on standard therapy. :@0.076190:0.218335:0.397319:0.218335:0.397319:0.202552:0.076190:0.202552:0.009162:0.004188:0.006804:0.007529:0.009827:0.008376:0.009827:0.004551:0.009827:0.004188:0.005866:0.003024:0.010357:0.009827:0.004188:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004188:0.009903:0.009223:0.004188:0.005866:0.005125:0.010326:0.009223:0.010357:0.010326:0.004551:0.010357:0.004188:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.004188
•  Severe  tophaceous  gout  with  the  risk  of  functional :@0.076190:0.232444:0.485130:0.232444:0.485130:0.216661:0.076190:0.216661:0.009162:0.004188:0.006804:0.007529:0.009827:0.008376:0.009827:0.004551:0.009827:0.004188:0.002585:0.005125:0.009903:0.010311:0.009223:0.010326:0.009782:0.009827:0.009903:0.009192:0.005866:0.004188:0.002585:0.010175:0.009903:0.009192:0.005125:0.004188:0.002585:0.012564:0.003024:0.005125:0.009223:0.004188:0.002600:0.005125:0.009223:0.009827:0.004188:0.002585:0.004551:0.003024:0.005866:0.007590:0.004188:0.002600:0.009903:0.004747:0.004188:0.002585:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.010326:0.003024:0.004188
loss of joints, e.g. tendon  rupture  and loss of hand :@0.096344:0.246552:0.485115:0.246552:0.485115:0.230770:0.096344:0.230770:0.003024:0.009903:0.005866:0.005866:0.006864:0.009903:0.004747:0.006864:0.003069:0.009903:0.003024:0.009223:0.005125:0.005866:0.004188:0.006864:0.009827:0.004188:0.010175:0.004188:0.006864:0.005125:0.009827:0.009223:0.010357:0.009903:0.009223:0.004188:0.002661:0.004551:0.009192:0.010311:0.005125:0.009192:0.004551:0.009827:0.004188:0.002661:0.010326:0.009223:0.010357:0.006864:0.003024:0.009903:0.005866:0.005866:0.006864:0.009903:0.004747:0.006864:0.009223:0.010326:0.009223:0.010357:0.004188
function.:@0.096344:0.260661:0.160751:0.260661:0.160751:0.244878:0.096344:0.244878:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
referenCes::@0.076190:0.293537:0.187802:0.293537:0.187802:0.273372:0.076190:0.273372:0.010718:0.009609:0.008870:0.009609:0.010718:0.009609:0.013674:0.014413:0.009609:0.009609:0.005174
1. :@0.076190:0.305431:0.089220:0.305431:0.089220:0.293156:0.076190:0.293156:0.006515:0.003257:0.003257
Ragab G, Elshahaly M, Bardin T. Gout: An old disease in a new per-:@0.101390:0.305431:0.480956:0.305431:0.480956:0.293156:0.101390:0.293156:0.007138:0.008032:0.007914:0.008032:0.008020:0.003234:0.010254:0.003257:0.003222:0.006303:0.002352:0.004563:0.007173:0.008032:0.007173:0.008032:0.002352:0.006303:0.003234:0.010807:0.003257:0.003222:0.006750:0.008032:0.003540:0.008055:0.002352:0.007173:0.003234:0.005009:0.003257:0.003222:0.010254:0.007702:0.007150:0.003986:0.003257:0.003222:0.008702:0.007173:0.003222:0.007702:0.002352:0.008055:0.003234:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003234:0.002352:0.007173:0.003234:0.008032:0.003234:0.007173:0.007644:0.009772:0.003222:0.008020:0.007644:0.003540:0.003904
spective – a review. :@0.101390:0.316333:0.217384:0.316333:0.217384:0.304057:0.101390:0.304057:0.004563:0.008020:0.007644:0.007608:0.003986:0.002352:0.006515:0.007644:0.003257:0.005880:0.003257:0.008032:0.003257:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003257:0.003257
J Adv Res.:@0.217384:0.316333:0.275439:0.316333:0.275439:0.304057:0.217384:0.304057:0.005668:0.003257:0.008702:0.008055:0.006515:0.003257:0.007138:0.007644:0.004563:0.003257
 2017;8(5):495-511.:@0.275427:0.316333:0.379215:0.316333:0.379215:0.304057:0.275427:0.304057:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
2. :@0.076190:0.327234:0.089220:0.327234:0.089220:0.314959:0.076190:0.314959:0.006515:0.003257:0.003257
Dalbeth N, Merriman TR, stamp LK. Gout. :@0.101390:0.327234:0.337457:0.327234:0.337457:0.314959:0.101390:0.314959:0.008749:0.008032:0.002352:0.008020:0.007644:0.003986:0.007173:0.003410:0.008702:0.003257:0.003410:0.010807:0.007644:0.003540:0.003540:0.002352:0.011030:0.008032:0.007173:0.003410:0.005009:0.007138:0.003257:0.003410:0.005856:0.003986:0.008032:0.011030:0.008020:0.003410:0.005433:0.006950:0.003257:0.003410:0.010254:0.007702:0.007150:0.003986:0.003257:0.003257
Lancet. :@0.337610:0.327234:0.384001:0.327234:0.384001:0.314959:0.337610:0.314959:0.005433:0.008032:0.007173:0.007608:0.007644:0.003986:0.003257:0.003257
2016;388 (10055): :@0.384142:0.327234:0.484189:0.327234:0.484189:0.314959:0.384142:0.314959:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003422:0.004339:0.006515:0.006515:0.006515:0.006515:0.006515:0.004339:0.003257:0.003257
2039-52.2. :@0.101390:0.338136:0.160669:0.338136:0.160669:0.325860:0.101390:0.325860:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257:0.006515:0.003257:0.003257
3. :@0.076190:0.349037:0.089220:0.349037:0.089220:0.336762:0.076190:0.336762:0.006515:0.003257:0.003257
Mandal AK, Mount DB. The molecular physiology of uric acid ho-:@0.101390:0.349037:0.480956:0.349037:0.480956:0.336762:0.101390:0.336762:0.010807:0.008032:0.007173:0.008055:0.008032:0.002352:0.004621:0.008702:0.006950:0.003257:0.004610:0.010807:0.007702:0.007150:0.007173:0.003986:0.004610:0.008749:0.006750:0.003257:0.004621:0.005009:0.007173:0.007644:0.004610:0.011030:0.007702:0.002352:0.007644:0.007608:0.007150:0.002352:0.008032:0.003540:0.004610:0.008020:0.007173:0.006303:0.004563:0.002352:0.007702:0.002352:0.007702:0.007914:0.006303:0.004621:0.007702:0.003692:0.004610:0.007150:0.003540:0.002352:0.007608:0.004610:0.008032:0.007608:0.002352:0.008055:0.004621:0.007173:0.007702:0.003904
meostasis. :@0.101390:0.359939:0.162339:0.359939:0.162339:0.347663:0.101390:0.347663:0.011030:0.007644:0.007702:0.004563:0.003986:0.008032:0.004563:0.002352:0.004563:0.003257:0.003257
Annu Rev Physiol.:@0.162339:0.359939:0.261011:0.359939:0.261011:0.347663:0.162339:0.347663:0.008702:0.007173:0.007173:0.007150:0.003257:0.007138:0.007644:0.006515:0.003257:0.006961:0.007173:0.006303:0.004563:0.002352:0.007702:0.002352:0.003257
 2015;77:323-45.:@0.260999:0.359939:0.349593:0.359939:0.349593:0.347663:0.260999:0.347663:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
4. :@0.076190:0.370840:0.089220:0.370840:0.089220:0.358565:0.076190:0.358565:0.006515:0.003257:0.003257
so A, Thorens B. Uric acid transport and disease. :@0.101390:0.370840:0.378027:0.370840:0.378027:0.358565:0.101390:0.358565:0.005856:0.007702:0.003481:0.008702:0.003257:0.003492:0.005009:0.007173:0.007702:0.003540:0.007644:0.007173:0.004563:0.003481:0.006750:0.003257:0.003492:0.007702:0.003540:0.002352:0.007608:0.003481:0.008032:0.007608:0.002352:0.008055:0.003492:0.003986:0.003540:0.008032:0.007173:0.004563:0.008020:0.007702:0.003540:0.003986:0.003481:0.008032:0.007173:0.008055:0.003492:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257
J Clin Invest. :@0.378262:0.370840:0.451405:0.370840:0.451405:0.358565:0.378262:0.358565:0.005668:0.003492:0.009560:0.002352:0.002352:0.007173:0.003492:0.002658:0.007173:0.006515:0.007644:0.004563:0.003986:0.003257:0.003257
2010; :@0.451640:0.370840:0.484213:0.370840:0.484213:0.358565:0.451640:0.358565:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
120(6):1791-9.:@0.101390:0.381742:0.179119:0.381742:0.179119:0.369466:0.101390:0.369466:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.003257
5. :@0.076190:0.392643:0.089220:0.392643:0.089220:0.380368:0.076190:0.380368:0.006515:0.003257:0.003257
Beyl RN Jr, Hughes L, Morgan s. Update on importance of diet in :@0.101390:0.392643:0.484201:0.392643:0.484201:0.380368:0.101390:0.380368:0.006750:0.007644:0.006303:0.002352:0.004539:0.007138:0.008702:0.004527:0.005668:0.003540:0.003257:0.004527:0.008032:0.007150:0.007914:0.007173:0.007644:0.004563:0.004539:0.005433:0.003257:0.004527:0.010807:0.007702:0.003540:0.007914:0.008032:0.007173:0.004539:0.005856:0.003257:0.004539:0.007702:0.008020:0.008055:0.008032:0.003986:0.007644:0.004539:0.007702:0.007173:0.004527:0.002352:0.011030:0.008020:0.007702:0.003540:0.003986:0.008032:0.007173:0.007608:0.007644:0.004527:0.007702:0.003692:0.004527:0.008055:0.002352:0.007644:0.003986:0.004539:0.002352:0.007173:0.003257
gout. :@0.101390:0.403545:0.134657:0.403545:0.134657:0.391269:0.101390:0.391269:0.007914:0.007702:0.007150:0.003986:0.003257:0.003257
Am J Med.:@0.134646:0.403545:0.196323:0.403545:0.196323:0.391269:0.134646:0.391269:0.008702:0.011030:0.003257:0.005668:0.003257:0.010807:0.007644:0.008055:0.003257
 2016;129(11):1153-8.:@0.196311:0.403545:0.313128:0.403545:0.313128:0.391269:0.196311:0.391269:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.003257
6. :@0.076190:0.414446:0.089220:0.414446:0.089220:0.402171:0.076190:0.402171:0.006515:0.003257:0.003257
Klippel JH, :@0.101390:0.414446:0.161986:0.414446:0.161986:0.402171:0.101390:0.402171:0.006950:0.002352:0.002352:0.008020:0.008020:0.007644:0.002352:0.002693:0.005668:0.008032:0.003257:0.003257
et al.:@0.161410:0.414446:0.189361:0.414446:0.189361:0.402171:0.161410:0.402171:0.007644:0.003986:0.002681:0.008032:0.002352:0.003257
 primer on the rheumatic diseases. New York: spring-:@0.189361:0.414446:0.480956:0.414446:0.480956:0.402171:0.189361:0.402171:0.002681:0.006961:0.003540:0.002352:0.011030:0.007644:0.003540:0.002669:0.007702:0.007173:0.002681:0.003986:0.007173:0.007644:0.002681:0.003540:0.007173:0.007644:0.007150:0.011030:0.008032:0.003986:0.002352:0.007608:0.002681:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.004563:0.003257:0.002693:0.008702:0.007644:0.009772:0.002681:0.006961:0.007702:0.003540:0.005903:0.003257:0.002658:0.005856:0.008020:0.003540:0.002352:0.007173:0.007914:0.003904
er-Verlag; 2008. :@0.101390:0.425348:0.193301:0.425348:0.193301:0.413072:0.101390:0.413072:0.007644:0.003540:0.003904:0.008255:0.007644:0.003540:0.002352:0.008032:0.007914:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
7. :@0.076190:0.436249:0.089220:0.436249:0.089220:0.423974:0.076190:0.423974:0.006515:0.003257:0.003257
Neogi T, :@0.101390:0.436249:0.151896:0.436249:0.151896:0.423974:0.101390:0.423974:0.008702:0.007644:0.007702:0.007914:0.002352:0.004668:0.005009:0.003257:0.003257
et al.:@0.153308:0.436249:0.183247:0.436249:0.183247:0.423974:0.153308:0.423974:0.007644:0.003986:0.004668:0.008032:0.002352:0.003257
 2015 Gout classification criteria: An American Col:@0.183247:0.436249:0.477040:0.436249:0.477040:0.423974:0.183247:0.423974:0.004680:0.006515:0.006515:0.006515:0.006515:0.004680:0.010254:0.007702:0.007150:0.003986:0.004668:0.007608:0.002352:0.008032:0.004563:0.004563:0.002352:0.002863:0.002863:0.007620:0.008032:0.003986:0.002352:0.007702:0.007173:0.004668:0.007608:0.003540:0.002352:0.003986:0.007644:0.003540:0.002352:0.008032:0.003257:0.004668:0.008702:0.007173:0.004668:0.008702:0.011030:0.007644:0.003540:0.002352:0.007608:0.008032:0.007173:0.004668:0.009560:0.007702:0.002352
-:@0.477040:0.436249:0.480944:0.436249:0.480944:0.423974:0.477040:0.423974:0.003904
lege of Rheumatology/European League Against Rheumatism col-:@0.101390:0.447150:0.480967:0.447150:0.480967:0.434875:0.101390:0.434875:0.002352:0.007644:0.007914:0.007644:0.003269:0.007702:0.003692:0.003269:0.007138:0.007173:0.007644:0.007150:0.011030:0.008032:0.003986:0.007702:0.002352:0.007702:0.007914:0.006303:0.005139:0.006303:0.007150:0.003540:0.007702:0.008020:0.007644:0.008032:0.007173:0.003257:0.005433:0.007644:0.008032:0.007914:0.007150:0.007644:0.003269:0.008702:0.007914:0.008032:0.002352:0.007173:0.004563:0.003986:0.003269:0.007138:0.007173:0.007644:0.007150:0.011030:0.008032:0.003986:0.002352:0.004563:0.011030:0.003269:0.007608:0.007702:0.002352:0.003904
laborative initiative. :@0.101390:0.458052:0.216078:0.458052:0.216078:0.445777:0.101390:0.445777:0.002352:0.008032:0.008020:0.007702:0.003540:0.008032:0.003986:0.002352:0.006515:0.007644:0.003257:0.002352:0.007173:0.002352:0.003986:0.002352:0.008032:0.003986:0.002352:0.006515:0.007644:0.003257:0.003257
Ann Rheum Dis. :@0.216078:0.458052:0.307953:0.458052:0.307953:0.445777:0.216078:0.445777:0.008702:0.007173:0.007173:0.003257:0.007138:0.007173:0.007644:0.007150:0.011030:0.003257:0.008749:0.002352:0.004563:0.003257:0.003257
2015;74(10):1789-98.:@0.307942:0.458052:0.421501:0.458052:0.421501:0.445777:0.307942:0.445777:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
8. :@0.076190:0.468953:0.089220:0.468953:0.089220:0.456678:0.076190:0.456678:0.006515:0.003257:0.003257
Abrahams MN. Gout and hyperuricaemia. :@0.101390:0.468953:0.345560:0.468953:0.345560:0.456678:0.101390:0.456678:0.008702:0.008020:0.003540:0.008032:0.007173:0.008032:0.011030:0.004563:0.003257:0.010807:0.008702:0.003257:0.003257:0.010254:0.007702:0.007150:0.003986:0.003257:0.008032:0.007173:0.008055:0.003257:0.007173:0.006303:0.008020:0.007644:0.003540:0.007150:0.003540:0.002352:0.007608:0.008032:0.007644:0.011030:0.002352:0.008032:0.003257:0.003257
SAMJ. :@0.345536:0.468953:0.383083:0.468953:0.383083:0.456678:0.345536:0.456678:0.005856:0.008702:0.010807:0.005668:0.003257:0.003257
2015;105(12).:@0.383072:0.468953:0.456896:0.468953:0.456896:0.456678:0.383072:0.456678:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.006515:0.004339:0.003257
9. :@0.076190:0.479855:0.089220:0.479855:0.089220:0.467579:0.076190:0.467579:0.006515:0.003257:0.003257
Gaber W, Ezzat Y, Abd El, Rahman sF. Role of diagnostic ultrasonog-:@0.101390:0.479855:0.480956:0.479855:0.480956:0.467579:0.101390:0.467579:0.010254:0.008032:0.008020:0.007644:0.003540:0.002634:0.011289:0.003257:0.002634:0.006303:0.004998:0.004998:0.008032:0.003986:0.002622:0.006961:0.003257:0.002622:0.008702:0.008020:0.008055:0.002634:0.006303:0.002352:0.003257:0.002634:0.007138:0.008032:0.007173:0.011030:0.008032:0.007173:0.002634:0.005856:0.005703:0.003257:0.002634:0.007138:0.007702:0.002352:0.007644:0.002634:0.007702:0.003692:0.002622:0.008055:0.002352:0.008032:0.007914:0.007173:0.007702:0.004563:0.003986:0.002352:0.007608:0.002634:0.007150:0.002352:0.003986:0.003540:0.008032:0.004563:0.007702:0.007173:0.007702:0.007902:0.003904
raphy in detecting gouty arthritis. :@0.101390:0.490756:0.303944:0.490756:0.303944:0.478481:0.101390:0.478481:0.003540:0.008032:0.008020:0.007173:0.006303:0.006127:0.002352:0.007173:0.006127:0.008055:0.007644:0.003986:0.007644:0.007608:0.003986:0.002352:0.007173:0.007914:0.006127:0.007914:0.007702:0.007150:0.003986:0.006303:0.006127:0.008032:0.003540:0.003986:0.007173:0.003540:0.002352:0.003986:0.002352:0.004563:0.003257:0.003257
The Egyptian Rheumatologist. :@0.306813:0.490756:0.484213:0.490756:0.484213:0.478481:0.306813:0.478481:0.005009:0.007173:0.007644:0.006127:0.006303:0.007914:0.006303:0.008020:0.003986:0.002352:0.008032:0.007173:0.006127:0.007138:0.007173:0.007644:0.007150:0.011030:0.008032:0.003986:0.007702:0.002352:0.007702:0.007914:0.002352:0.004563:0.003986:0.003257:0.003257
2013;35(2):71-5.:@0.101390:0.501658:0.188891:0.501658:0.188891:0.489382:0.101390:0.489382:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.003257
10.  Nicolaou s, :@0.076190:0.512559:0.169735:0.512559:0.169735:0.500284:0.076190:0.500284:0.006515:0.006515:0.003257:0.003257:0.005656:0.008702:0.002352:0.007608:0.007702:0.002352:0.008032:0.007702:0.007150:0.004374:0.005856:0.003257:0.003257
et al. :@0.170852:0.512559:0.203755:0.512559:0.203755:0.500284:0.170852:0.500284:0.007644:0.003986:0.004374:0.008032:0.002352:0.003257:0.003257
Dual-energy CT: A promising new technique for :@0.204872:0.512559:0.484225:0.512559:0.484225:0.500284:0.204872:0.500284:0.008749:0.007150:0.008032:0.002352:0.003904:0.007644:0.007173:0.007644:0.003540:0.007914:0.006303:0.004374:0.009560:0.005009:0.003257:0.004374:0.008702:0.004374:0.008020:0.003540:0.007702:0.011030:0.002352:0.004563:0.002352:0.007173:0.007914:0.004374:0.007173:0.007644:0.009772:0.004374:0.003986:0.007644:0.007608:0.007173:0.007173:0.002352:0.008020:0.007150:0.007644:0.004374:0.003692:0.007702:0.003540:0.003257
assessment of the musculoskeletal system. :@0.101390:0.523461:0.348805:0.523461:0.348805:0.511185:0.101390:0.511185:0.008032:0.004563:0.004563:0.007644:0.004563:0.004563:0.011030:0.007644:0.007173:0.003986:0.004715:0.007702:0.003692:0.004704:0.003986:0.007173:0.007644:0.004704:0.011030:0.007150:0.004563:0.007608:0.007150:0.002352:0.007702:0.004563:0.005903:0.007644:0.002352:0.007644:0.003986:0.008032:0.002352:0.004704:0.004563:0.006303:0.004563:0.003986:0.007644:0.011030:0.003257:0.003257
AJR Am J Roentgenol. :@0.350263:0.523461:0.484225:0.523461:0.484225:0.511185:0.350263:0.511185:0.008702:0.005668:0.007138:0.004704:0.008702:0.011030:0.004704:0.005668:0.004704:0.007138:0.007702:0.007644:0.007173:0.003986:0.007914:0.007644:0.007173:0.007702:0.002352:0.003257:0.003257
2012;199(5 suppl):s78-86.:@0.101390:0.534362:0.242431:0.534362:0.242431:0.522087:0.101390:0.522087:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.003257:0.005856:0.007150:0.008020:0.008020:0.002352:0.004339:0.003257:0.005856:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
11.  Chou H, Chin TY, peh WCG. Dual-energy CT in gout – a review of cur-:@0.076190:0.545264:0.481014:0.545264:0.481014:0.532988:0.076190:0.532988:0.006515:0.006515:0.003257:0.003257:0.005656:0.009443:0.007056:0.007585:0.007032:0.002787:0.007914:0.003140:0.002787:0.009443:0.007056:0.002234:0.007056:0.002787:0.004892:0.006844:0.003140:0.002787:0.006844:0.007526:0.007056:0.002787:0.011171:0.009443:0.010136:0.003140:0.002787:0.008631:0.007032:0.007914:0.002234:0.003786:0.007526:0.007056:0.007526:0.003422:0.007796:0.006185:0.002787:0.009443:0.004892:0.002787:0.002234:0.007056:0.002787:0.007796:0.007585:0.007032:0.003869:0.002787:0.005762:0.002787:0.007914:0.002787:0.003422:0.007526:0.006397:0.002234:0.007526:0.009654:0.002787:0.007585:0.003575:0.002787:0.007491:0.007032:0.003422:0.003904
rent concepts and applications. :@0.101390:0.556165:0.284129:0.556165:0.284129:0.543890:0.101390:0.543890:0.003422:0.007526:0.007056:0.003869:0.003140:0.007491:0.007585:0.007056:0.007491:0.007526:0.007902:0.003869:0.004445:0.003140:0.007914:0.007056:0.007937:0.003140:0.007914:0.007902:0.007902:0.002234:0.002234:0.007491:0.007914:0.003869:0.002234:0.007585:0.007056:0.004445:0.003140:0.003257
J Med Radiat Sci. :@0.284012:0.556165:0.383883:0.556165:0.383883:0.543890:0.284012:0.543890:0.005550:0.003140:0.010689:0.007526:0.007937:0.003140:0.007020:0.007914:0.007937:0.002234:0.007914:0.003869:0.003140:0.005739:0.007491:0.002234:0.003140:0.003257
2017;64(1):41-51.:@0.383765:0.556165:0.475899:0.556165:0.475899:0.543890:0.383765:0.543890:0.006397:0.006397:0.006397:0.006397:0.003140:0.006397:0.006397:0.004222:0.006397:0.004222:0.003140:0.006397:0.006397:0.003786:0.006397:0.006397:0.003257
12.  Krishnan E, :@0.076190:0.567067:0.164161:0.567067:0.164161:0.554791:0.076190:0.554791:0.006515:0.006515:0.003257:0.003257:0.005656:0.006950:0.003540:0.002352:0.004563:0.007173:0.007173:0.008032:0.007173:0.002999:0.006303:0.003257:0.003257
et al. :@0.163914:0.567067:0.195453:0.567067:0.195453:0.554791:0.163914:0.554791:0.007644:0.003986:0.003010:0.008032:0.002352:0.003257:0.003257
Hyperuricemia and untreated gout are poor prog-:@0.195206:0.567067:0.480956:0.567067:0.480956:0.554791:0.195206:0.554791:0.008032:0.006303:0.008020:0.007644:0.003540:0.007150:0.003540:0.002352:0.007608:0.007644:0.011030:0.002352:0.008032:0.003010:0.008032:0.007173:0.008055:0.003010:0.007150:0.007173:0.003986:0.003540:0.007644:0.008032:0.003986:0.007644:0.008055:0.002999:0.007914:0.007702:0.007150:0.003986:0.002999:0.008032:0.003540:0.007644:0.003010:0.008020:0.007702:0.007702:0.003540:0.002999:0.008020:0.003540:0.007702:0.007914:0.003904
nostic markers among those with a recent acute myocardial infarc-:@0.101390:0.577968:0.480944:0.577968:0.480944:0.565693:0.101390:0.565693:0.007173:0.007702:0.004563:0.003986:0.002352:0.007608:0.002705:0.011030:0.008032:0.003540:0.005903:0.007644:0.003540:0.004563:0.002705:0.008032:0.011030:0.007702:0.007173:0.007914:0.002705:0.003986:0.007173:0.007702:0.004563:0.007644:0.002705:0.009772:0.002352:0.003986:0.007173:0.002705:0.008032:0.002716:0.003540:0.007644:0.007608:0.007644:0.007173:0.003986:0.002705:0.008032:0.007608:0.007150:0.003986:0.007644:0.002705:0.011030:0.006303:0.007702:0.007608:0.008032:0.003540:0.008055:0.002352:0.008032:0.002352:0.002716:0.002352:0.007173:0.003692:0.008032:0.003540:0.007608:0.003904
tion. :@0.101390:0.588870:0.129119:0.588870:0.129119:0.576594:0.101390:0.576594:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257
Arthritis Res Ther. :@0.129107:0.588870:0.225039:0.588870:0.225039:0.576594:0.129107:0.576594:0.008702:0.003540:0.003986:0.007173:0.003540:0.002352:0.003986:0.002352:0.004563:0.003257:0.007138:0.007644:0.004563:0.003257:0.005009:0.007173:0.007644:0.003540:0.003257:0.003257
2012;14(1):@0.225015:0.588870:0.282553:0.588870:0.282553:0.576594:0.225015:0.576594:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339
13.  Van Echteld I, :@0.076179:0.599771:0.187092:0.599771:0.187092:0.587496:0.076179:0.587496:0.006515:0.006515:0.003257:0.003257:0.005656:0.008255:0.008032:0.007173:0.004986:0.006303:0.007608:0.007173:0.003986:0.007644:0.002352:0.008055:0.004974:0.002658:0.003257:0.003257
et al.:@0.188809:0.599771:0.219054:0.599771:0.219054:0.587496:0.188809:0.587496:0.007644:0.003986:0.004974:0.008032:0.002352:0.003257
 Colchicine for acute gout. :@0.219054:0.599771:0.383095:0.599771:0.383095:0.587496:0.219054:0.587496:0.004974:0.009560:0.007702:0.002352:0.007608:0.007173:0.002352:0.007608:0.002352:0.007173:0.007644:0.004974:0.003692:0.007702:0.003540:0.004974:0.008032:0.007608:0.007150:0.003986:0.007644:0.004974:0.007914:0.007702:0.007150:0.003986:0.003257:0.003257
Cochrane Data-:@0.384824:0.599771:0.480932:0.599771:0.480932:0.587496:0.384824:0.587496:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.004974:0.008749:0.008032:0.003986:0.008032:0.003904
base Syst Rev. :@0.101367:0.610672:0.184658:0.610672:0.184658:0.598397:0.101367:0.598397:0.008020:0.008032:0.004563:0.007644:0.003257:0.005856:0.006303:0.004563:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.003257
2014;(8):@0.184658:0.610672:0.229166:0.610672:0.229166:0.598397:0.184658:0.598397:0.006515:0.006515:0.006515:0.006515:0.003257:0.004339:0.006515:0.004339
14.  Richette p, :@0.076167:0.621574:0.162033:0.621574:0.162033:0.609299:0.076167:0.609299:0.006515:0.006515:0.003257:0.003257:0.005656:0.006785:0.001999:0.007255:0.006820:0.007291:0.003634:0.003634:0.007291:0.003187:0.006609:0.002905:0.003257
et al. :@0.161962:0.621574:0.191913:0.621574:0.191913:0.609299:0.161962:0.609299:0.007291:0.003634:0.003187:0.007679:0.001999:0.002905:0.003257
2016 updated EULAR evidence-based recommenda-:@0.191843:0.621574:0.480967:0.621574:0.480967:0.609299:0.191843:0.609299:0.006162:0.006162:0.006162:0.006162:0.003187:0.006797:0.007667:0.007702:0.007679:0.003634:0.007291:0.007702:0.003187:0.005950:0.007350:0.005080:0.008349:0.006785:0.003187:0.007291:0.006162:0.001999:0.007702:0.007291:0.006820:0.007255:0.007291:0.003551:0.007667:0.007679:0.004210:0.007291:0.007702:0.003187:0.003187:0.007291:0.007255:0.007350:0.010677:0.010677:0.007291:0.006820:0.007702:0.007679:0.003904
tions for the management of gout. :@0.101367:0.632475:0.289844:0.632475:0.289844:0.620200:0.101367:0.620200:0.003634:0.001999:0.007350:0.006820:0.004210:0.002905:0.003340:0.007350:0.003187:0.002905:0.003634:0.006820:0.007291:0.002905:0.010677:0.007679:0.006820:0.007679:0.007561:0.007291:0.010677:0.007291:0.006820:0.003634:0.002905:0.007350:0.003340:0.002905:0.007561:0.007350:0.006797:0.003634:0.002905:0.003257
Ann Rheum Dis.:@0.289491:0.632475:0.373523:0.632475:0.373523:0.620200:0.289491:0.620200:0.008349:0.006820:0.006820:0.002905:0.006785:0.006820:0.007291:0.006797:0.010677:0.002905:0.008396:0.001999:0.004210:0.003257
 2017;76(1):29-42.:@0.373170:0.632475:0.464446:0.632475:0.464446:0.620200:0.373170:0.620200:0.002905:0.006162:0.006162:0.006162:0.006162:0.002905:0.006162:0.006162:0.003986:0.006162:0.003986:0.002905:0.006162:0.006162:0.003551:0.006162:0.006162:0.003257
15.  Hill EM, sky K, sit M, :@0.076167:0.643377:0.218195:0.643377:0.218195:0.631102:0.076167:0.631102:0.006515:0.006515:0.003257:0.003257:0.005656:0.008032:0.002352:0.002352:0.002352:0.004727:0.006303:0.010807:0.003257:0.004715:0.005856:0.005903:0.006303:0.004715:0.006950:0.003257:0.004715:0.005856:0.002352:0.003986:0.004715:0.010807:0.003257:0.003257
et al.:@0.219653:0.643377:0.249639:0.643377:0.249639:0.631102:0.219653:0.631102:0.007644:0.003986:0.004715:0.008032:0.002352:0.003257
 Does starting allopurinol prolong acute :@0.249639:0.643377:0.484213:0.643377:0.484213:0.631102:0.249639:0.631102:0.004715:0.008749:0.007702:0.007644:0.004563:0.004715:0.004563:0.003986:0.008032:0.003540:0.003986:0.002352:0.007173:0.007914:0.004715:0.008032:0.002352:0.002352:0.007702:0.008020:0.007150:0.003540:0.002352:0.007173:0.007702:0.002352:0.004715:0.008020:0.003540:0.007702:0.002352:0.007702:0.007173:0.007914:0.004704:0.008032:0.007608:0.007150:0.003986:0.007644:0.003257
treated gout? A randomized clinical trial. :@0.101367:0.654278:0.344313:0.654278:0.344313:0.642003:0.101367:0.642003:0.003986:0.003540:0.007644:0.008032:0.003986:0.007644:0.008055:0.004492:0.007914:0.007702:0.007150:0.003986:0.006950:0.004492:0.008702:0.004492:0.003540:0.008032:0.007173:0.008055:0.007702:0.011030:0.002352:0.004998:0.007644:0.008055:0.004492:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.004504:0.003986:0.003540:0.002352:0.008032:0.002352:0.003257:0.003257
J Clin Rheumatol. :@0.345548:0.654278:0.450370:0.654278:0.450370:0.642003:0.345548:0.642003:0.005668:0.004492:0.009560:0.002352:0.002352:0.007173:0.004504:0.007138:0.007173:0.007644:0.007150:0.011030:0.008032:0.003986:0.007702:0.002352:0.003257:0.003257
2015; :@0.451604:0.654278:0.484178:0.654278:0.484178:0.642003:0.451604:0.642003:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
21:120-5.:@0.101367:0.665180:0.150873:0.665180:0.150873:0.652904:0.101367:0.652904:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.003257
16.  Nuki G, Doherty M, Richette p. Current management of gout: prac-:@0.076167:0.676081:0.480932:0.676081:0.480932:0.663806:0.076167:0.663806:0.006515:0.006515:0.003257:0.003257:0.005656:0.008702:0.007150:0.005903:0.002352:0.003140:0.010254:0.003257:0.003140:0.008749:0.007702:0.007173:0.007644:0.003540:0.003975:0.006303:0.003140:0.010807:0.003257:0.003140:0.007138:0.002352:0.007608:0.007173:0.007644:0.003986:0.003986:0.007644:0.003128:0.006961:0.003257:0.003140:0.009560:0.007150:0.003540:0.003540:0.007644:0.007173:0.003986:0.003128:0.011030:0.008032:0.007173:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.003128:0.007702:0.003692:0.003140:0.007914:0.007702:0.007150:0.003986:0.003257:0.003128:0.006961:0.003540:0.008032:0.007608:0.003904
tical messages from 2016 EULAR guidelines. :@0.101367:0.686983:0.350157:0.686983:0.350157:0.674707:0.101367:0.674707:0.003986:0.002352:0.007608:0.008032:0.002352:0.003504:0.011030:0.007644:0.004563:0.004563:0.008032:0.007914:0.007644:0.004563:0.003504:0.003692:0.003540:0.007702:0.011030:0.003492:0.006515:0.006515:0.006515:0.006515:0.003504:0.006303:0.007702:0.005433:0.008702:0.007138:0.003492:0.007914:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.004563:0.003257:0.003257
Polish Arch Intern Med. :@0.350404:0.686983:0.484201:0.686983:0.484201:0.674707:0.350404:0.674707:0.006961:0.007702:0.002352:0.002352:0.004563:0.007173:0.003492:0.008702:0.003540:0.007608:0.007173:0.003492:0.002658:0.007173:0.003986:0.007644:0.003540:0.007173:0.003492:0.010807:0.007644:0.008055:0.003257:0.003257
2017;127(4):267-77.:@0.101367:0.697884:0.208411:0.697884:0.208411:0.685609:0.101367:0.685609:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
17.  Khanna D, :@0.076167:0.708786:0.165373:0.708786:0.165373:0.696510:0.076167:0.696510:0.006515:0.006515:0.003257:0.003257:0.005656:0.006950:0.007173:0.008032:0.007173:0.007173:0.008032:0.004210:0.008749:0.003257:0.003257
et al.:@0.166325:0.708786:0.195805:0.708786:0.195805:0.696510:0.166325:0.696510:0.007644:0.003986:0.004210:0.008032:0.002352:0.003257
 2012 American College of Rheumatology guide-:@0.195805:0.708786:0.480909:0.708786:0.480909:0.696510:0.195805:0.696510:0.004210:0.006515:0.006515:0.006515:0.006515:0.004222:0.008702:0.011030:0.007644:0.003540:0.002352:0.007608:0.008032:0.007173:0.004210:0.009560:0.007702:0.002352:0.002352:0.007644:0.007914:0.007644:0.004210:0.007702:0.003692:0.004210:0.007138:0.007173:0.007644:0.007150:0.011030:0.008032:0.003986:0.007691:0.002352:0.007702:0.007914:0.006303:0.004210:0.007914:0.007150:0.002352:0.008055:0.007644:0.003904
lines for management of gout. part 1: systematic nonpharmaco-:@0.101367:0.719687:0.480932:0.719687:0.480932:0.707412:0.101367:0.707412:0.002352:0.002352:0.007173:0.007644:0.004563:0.004845:0.003692:0.007702:0.003540:0.004845:0.011030:0.008032:0.007173:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.004845:0.007702:0.003692:0.004845:0.007914:0.007702:0.007150:0.003986:0.003257:0.004833:0.006961:0.008032:0.003540:0.003986:0.004845:0.006515:0.003257:0.004845:0.005856:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.004845:0.007173:0.007702:0.007173:0.008020:0.007173:0.008032:0.003540:0.011030:0.008032:0.007608:0.007702:0.003904
logic and pharmacologic therapeutic approaches to hyperurice-:@0.101367:0.730589:0.480932:0.730589:0.480932:0.718313:0.101367:0.718313:0.002352:0.007702:0.007914:0.002352:0.007608:0.004222:0.008032:0.007173:0.008055:0.004222:0.008020:0.007173:0.008032:0.003540:0.011030:0.008032:0.007608:0.007702:0.002352:0.007702:0.007914:0.002352:0.007608:0.004210:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.007644:0.007150:0.003986:0.002352:0.007608:0.004210:0.008032:0.008020:0.008020:0.003540:0.007702:0.008032:0.007608:0.007173:0.007644:0.004563:0.004210:0.003986:0.007702:0.004210:0.007173:0.006303:0.008020:0.007644:0.003540:0.007150:0.003540:0.002352:0.007608:0.007644:0.003904
mia. :@0.101367:0.741490:0.129295:0.741490:0.129295:0.729215:0.101367:0.729215:0.011030:0.002352:0.008032:0.003257:0.003257
Arthritis Care Res.:@0.129295:0.741490:0.227379:0.741490:0.227379:0.729215:0.129295:0.729215:0.008702:0.003540:0.003986:0.007173:0.003540:0.002352:0.003986:0.002352:0.004563:0.003257:0.009560:0.008032:0.003540:0.007644:0.003257:0.007138:0.007644:0.004563:0.003257
 2012;64(10):1431-46.:@0.227367:0.741490:0.344184:0.741490:0.344184:0.729215:0.227367:0.729215:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
18.  Jalal DI, :@0.076167:0.752392:0.149215:0.752392:0.149215:0.740116:0.076167:0.740116:0.006515:0.006515:0.003257:0.003257:0.005656:0.005668:0.008032:0.002352:0.008032:0.002352:0.003492:0.008749:0.002658:0.003257:0.003257
et al. :@0.149439:0.752392:0.181447:0.752392:0.181447:0.740116:0.149439:0.740116:0.007644:0.003986:0.003481:0.008032:0.002352:0.003257:0.003257
Uric acid as a target of therapy in CKD. :@0.181671:0.752392:0.409871:0.752392:0.409871:0.740116:0.181671:0.740116:0.007702:0.003540:0.002352:0.007608:0.003481:0.008032:0.007608:0.002352:0.008055:0.003481:0.008032:0.004563:0.003481:0.008032:0.003481:0.003986:0.008032:0.003540:0.007914:0.007644:0.003986:0.003469:0.007702:0.003692:0.003481:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.003481:0.002352:0.007173:0.003481:0.009560:0.006950:0.008749:0.003257:0.003257
Am J Kidney :@0.410094:0.752392:0.484189:0.752392:0.484189:0.740116:0.410094:0.740116:0.008702:0.011030:0.003481:0.005668:0.003481:0.006950:0.002352:0.008055:0.007173:0.007644:0.006303:0.003257
Dis.:@0.101367:0.763293:0.120288:0.763293:0.120288:0.751018:0.101367:0.751018:0.008749:0.002352:0.004563:0.003257
 2013;61(1):134-46.:@0.120288:0.763293:0.224075:0.763293:0.224075:0.751018:0.120288:0.751018:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257